Regulation of dynorphin gene expression by κ-opioid agonist treatment

Stephanie Collins; Claudio D'Addario; Patrizia Romualdi; Sanzio Candeletti; Sari Izenwasser

doi:10.1097/00001756-200201210-00025

Regulation of dynorphin gene expression by κ-opioid agonist treatment

Stephanie Collins, Claudio D'Addario, Patrizia Romualdi, Sanzio Candeletti, Sari Izenwasser

Psychiatry & Behavioral Sciences

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Abstract

The effects of κ-opioid agonist treatment on prodynorphin mRNA expression in the rat brain were studied. Rats were treated with the selective κ-opioid agonist U-69593 or vehicle for 5 days and prodynorphin mRNA was measured on day 8 (3 days after the last injection) or 22 (17 days after the last injection). On day 8 prodynorphin mRNA was increased in the hypothalamus and decreased in the striatum, frontal cortex, and hippocampus of rats treated with U-69593. On day 22, prodynorphin mRNA was increased in the hypothalamus, frontal cortex and striatum of U-69593 treated rats. These findings suggests that κ-opioid receptor agonist treatment has long-term, continually changing effects on prodynorphin mRNA expression.

Original language	English (US)
Pages (from-to)	107-109
Number of pages	3
Journal	Neuroreport
Volume	13
Issue number	1
DOIs	https://doi.org/10.1097/00001756-200201210-00025
State	Published - Jan 21 2002

Keywords

κ-Opioid receptor
Cocaine
Dynorphin
U-69593

ASJC Scopus subject areas

Neuroscience(all)

Access to Document

10.1097/00001756-200201210-00025

Cite this

@article{5bfeec2bf51741a798ef38ce1948e18e,

title = "Regulation of dynorphin gene expression by κ-opioid agonist treatment",

abstract = "The effects of κ-opioid agonist treatment on prodynorphin mRNA expression in the rat brain were studied. Rats were treated with the selective κ-opioid agonist U-69593 or vehicle for 5 days and prodynorphin mRNA was measured on day 8 (3 days after the last injection) or 22 (17 days after the last injection). On day 8 prodynorphin mRNA was increased in the hypothalamus and decreased in the striatum, frontal cortex, and hippocampus of rats treated with U-69593. On day 22, prodynorphin mRNA was increased in the hypothalamus, frontal cortex and striatum of U-69593 treated rats. These findings suggests that κ-opioid receptor agonist treatment has long-term, continually changing effects on prodynorphin mRNA expression.",

keywords = "κ-Opioid receptor, Cocaine, Dynorphin, U-69593",

author = "Stephanie Collins and Claudio D'Addario and Patrizia Romualdi and Sanzio Candeletti and Sari Izenwasser",

year = "2002",

month = jan,

day = "21",

doi = "10.1097/00001756-200201210-00025",

language = "English (US)",

volume = "13",

pages = "107--109",

journal = "NeuroReport",

issn = "0959-4965",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Regulation of dynorphin gene expression by κ-opioid agonist treatment

AU - Collins, Stephanie

AU - D'Addario, Claudio

AU - Romualdi, Patrizia

AU - Candeletti, Sanzio

AU - Izenwasser, Sari

PY - 2002/1/21

Y1 - 2002/1/21

N2 - The effects of κ-opioid agonist treatment on prodynorphin mRNA expression in the rat brain were studied. Rats were treated with the selective κ-opioid agonist U-69593 or vehicle for 5 days and prodynorphin mRNA was measured on day 8 (3 days after the last injection) or 22 (17 days after the last injection). On day 8 prodynorphin mRNA was increased in the hypothalamus and decreased in the striatum, frontal cortex, and hippocampus of rats treated with U-69593. On day 22, prodynorphin mRNA was increased in the hypothalamus, frontal cortex and striatum of U-69593 treated rats. These findings suggests that κ-opioid receptor agonist treatment has long-term, continually changing effects on prodynorphin mRNA expression.

AB - The effects of κ-opioid agonist treatment on prodynorphin mRNA expression in the rat brain were studied. Rats were treated with the selective κ-opioid agonist U-69593 or vehicle for 5 days and prodynorphin mRNA was measured on day 8 (3 days after the last injection) or 22 (17 days after the last injection). On day 8 prodynorphin mRNA was increased in the hypothalamus and decreased in the striatum, frontal cortex, and hippocampus of rats treated with U-69593. On day 22, prodynorphin mRNA was increased in the hypothalamus, frontal cortex and striatum of U-69593 treated rats. These findings suggests that κ-opioid receptor agonist treatment has long-term, continually changing effects on prodynorphin mRNA expression.

KW - κ-Opioid receptor

KW - Cocaine

KW - Dynorphin

KW - U-69593

UR - http://www.scopus.com/inward/record.url?scp=0037148173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037148173&partnerID=8YFLogxK

U2 - 10.1097/00001756-200201210-00025

DO - 10.1097/00001756-200201210-00025

M3 - Article

C2 - 11924869

AN - SCOPUS:0037148173

VL - 13

SP - 107

EP - 109

JO - NeuroReport

JF - NeuroReport

SN - 0959-4965

IS - 1

ER -

Regulation of dynorphin gene expression by κ-opioid agonist treatment

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this